| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/24/2011 | WO2011090266A3 Novel tumor antigen protein agr2 and tumor antigenic peptide thereof |
| 11/24/2011 | WO2011087934A3 Kexin-derived vaccines to prevent or treat fungal infections |
| 11/24/2011 | WO2011085070A3 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
| 11/24/2011 | WO2011075605A3 Hyperglycosylated interferon variants and methods of use |
| 11/24/2011 | WO2011075539A3 Treatment of obesity or diabetes with bile acid sequestrants |
| 11/24/2011 | WO2011075516A3 Active scaffolds for on-demand drug and cell delivery |
| 11/24/2011 | WO2011066282A3 Methods and compositions for treating oxalate-related conditions |
| 11/24/2011 | WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 11/24/2011 | WO2011062786A3 Compounds and methods for inhibiting the metastasis of cancer cells |
| 11/24/2011 | WO2011056850A3 Linaclotide for the treatment of chronic constipation |
| 11/24/2011 | WO2011054001A3 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 11/24/2011 | WO2011053768A3 System and method for stabilizing corneal tissue after treatment |
| 11/24/2011 | WO2010144265A3 Ipamorelin diacetate injection and infusion solutions |
| 11/24/2011 | WO2010142461A3 Treatment of coagulopathy with hyperfibrinolysis |
| 11/24/2011 | WO2010128524A8 Combined measles-malaria vaccine |
| 11/24/2011 | WO2010025435A3 Controlled-released peptide formulations |
| 11/24/2011 | WO2007084527A8 Proteins containing a fluorinated amino acid, and methods of using same |
| 11/24/2011 | WO2006039533A3 Bcr-abl imatinib resistance-associated peptides and methods of use thereof |
| 11/24/2011 | US20110289611 Rna sequence-specific mediators of rna interference |
| 11/24/2011 | US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease |
| 11/24/2011 | US20110288651 Supercritical Carbon-Dioxide Processed Biodegradable Polymer Nanocomposites |
| 11/24/2011 | US20110288363 Biologically Enhanced Irrigants |
| 11/24/2011 | US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/24/2011 | US20110288271 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 11/24/2011 | US20110288036 Methods for Treating or Preventing Vascular Graft Failure |
| 11/24/2011 | US20110288035 Pimap39 modulates inflammatory response |
| 11/24/2011 | US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 11/24/2011 | US20110288033 Disulfide Compounds for Phototherapy |
| 11/24/2011 | US20110288032 Enzastaurin for the treatment of cancer |
| 11/24/2011 | US20110288031 Identification of a novel bhd gene |
| 11/24/2011 | US20110288030 Paralytic Peptide for Use in Neuromuscular Therapy |
| 11/24/2011 | US20110288029 Method for inhibiting neuronal cell death |
| 11/24/2011 | US20110288028 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 11/24/2011 | US20110288027 Targets, methods, and reagents for diagnosis and treatment of schizophrenia |
| 11/24/2011 | US20110288026 Electroprocessed Collagen and Tissue Engineering |
| 11/24/2011 | US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof |
| 11/24/2011 | US20110288024 Compositions and Methods for Treating Arthritis and/or Diseases Involving Cartilage Degeneration |
| 11/24/2011 | US20110288023 Cancer drug delivery using modified transferrin |
| 11/24/2011 | US20110288022 Treatment of depressive disorders |
| 11/24/2011 | US20110288021 Administration of angiocidin for the treatment of cancer |
| 11/24/2011 | US20110288020 Use of VEGF and homologues to treat neuron disorders |
| 11/24/2011 | US20110288019 Methods of increasing platelet and hematopoietic stem cell production |
| 11/24/2011 | US20110288018 Beverage lowering serum cholesterol |
| 11/24/2011 | US20110288017 Apo-lipoprotein propeptide |
| 11/24/2011 | US20110288016 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 11/24/2011 | US20110288015 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 11/24/2011 | US20110288014 Methods and compositions for diabetes treatment and prevention |
| 11/24/2011 | US20110288013 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2 |
| 11/24/2011 | US20110288012 Nutrition composition |
| 11/24/2011 | US20110288011 Peptide therapeutic conjugates and uses thereof |
| 11/24/2011 | US20110288010 Utilization of peptides as active ingredients for slimming |
| 11/24/2011 | US20110288009 Leptin and leptin analog conjugates and uses thereof |
| 11/24/2011 | US20110288008 Antibacterial and plasmid elimination agents |
| 11/24/2011 | US20110288007 Biocidal fusion peptide comprising ll-37 |
| 11/24/2011 | US20110288006 Peptides and methods for inducing cell death |
| 11/24/2011 | US20110288005 Alpha 1-antitrypsin compositions and methods of making and using same |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110288003 Amide based glucagon and superfamily peptide prodrugs |
| 11/24/2011 | US20110288002 Novel bag proteins and nucleic acid molecules encoding them |
| 11/24/2011 | US20110288001 Biologically active proteins activatable by peptidase |
| 11/24/2011 | US20110287513 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 11/24/2011 | US20110287466 Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates |
| 11/24/2011 | US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT |
| 11/24/2011 | US20110287262 Nanoparticles, nanocapsules and nanogels |
| 11/24/2011 | US20110287112 Prostate cancer progression inhibitor and progression inhibition method |
| 11/24/2011 | US20110287090 Compositions and Methods for Inhibiting Expression of a Mutant Gene |
| 11/24/2011 | US20110287083 Bioabsorbable Composition and Coatings Including Same |
| 11/24/2011 | US20110287080 Coating ii |
| 11/24/2011 | US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same |
| 11/24/2011 | US20110287068 Fibrin and fibrinogen matrices and uses of same |
| 11/24/2011 | US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof |
| 11/24/2011 | US20110287061 Dietary composition and method for promoting healthy hair growth and melanogenesis |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287045 Enhanced immune response against infections |
| 11/24/2011 | US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/24/2011 | US20110287040 Materials and methods for treatment of inflammation |
| 11/24/2011 | US20110287033 Use of ferritin to treat iron disorders |
| 11/24/2011 | US20110287031 Covalently reactive transition state analogs and methods of use thereof |
| 11/24/2011 | US20110287024 Vascular endothelial cell growth factor antagonists |
| 11/24/2011 | US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof |
| 11/24/2011 | US20110287021 Neoplasm specific antibodies and uses thereof |
| 11/24/2011 | US20110287010 Diagnostic methods and markers |
| 11/24/2011 | US20110287004 Mg53 compositions and methods of use |
| 11/24/2011 | US20110287001 Method of treatment |
| 11/24/2011 | US20110286998 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 11/24/2011 | US20110286997 Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes |
| 11/24/2011 | US20110286995 Drug Therapy for Celiac Sprue |
| 11/24/2011 | US20110286994 Methods and compositions for improving growth of meat-type poultry |
| 11/24/2011 | US20110286993 Use of hsp70 as a regulator of enzymatic activity |
| 11/24/2011 | US20110286991 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same |
| 11/24/2011 | US20110286990 Methods of diagnosing and treating fibrosis |
| 11/24/2011 | US20110286989 ANGIOGENIN COMPLEXES (ANGex) WITH LIPID-BASED SUBSTRATES AND USES THEREOF |
| 11/24/2011 | US20110286988 FVIII Muteins for Treatment of Von Willebrand Disease |
| 11/24/2011 | US20110286986 Lactoferrin and angiogenin compositions and uses thereof |
| 11/24/2011 | US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 11/24/2011 | US20110286982 Glucagon analogues |
| 11/24/2011 | US20110286981 Glucagon analogues |
| 11/24/2011 | US20110286976 Bi-specific fusion proteins |
| 11/24/2011 | US20110286969 Deuterated compounds as hepatitis c virus (hcv) inhibitors |
| 11/24/2011 | US20110286968 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |